EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease– a survey of the NeuroCOVID-19 task force of the European Academy of Neurology

Sonja Hochmeister, Martin Rakusa, Elena Moro, Daniel Bereczki, Francesco Cavallieri, Alessandra Fanciulli, Saša R Filipović, Alla Guekht, Raimund Helbok, Filippo Martinelli Boneschi, Serefnur Özturk, Alberto Priori und 3 weitere

Neurological Sciences · 2025

DOI: 10.1007/s10072-025-08017-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Sonja Hochmeister und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: COVID-19, Nervous System Diseases, Vaccination Hesitancy, COVID-19 Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An online 3-item survey was sent to the European Academy of Neurology (EAN) community and inquired about the persistence of SARS-CoV-2 vaccination skepticism and the underlying thoughts and factors restricting vaccine use among patients with neurological conditions.

Results

We obtained 616 responses from 84 countries, predominantly from Europe. In the view of the treating neurologist, patients with multiple sclerosis (MS), neuroimmunological disorders (ND), and chronic neurological infections continued to have high levels of skepticism toward SARS-CoV-2 vaccination. Patients with MS/ND were quoted as the most hesitant group, with 60% of the respondents sharing this impression. The patient group perceived as most confident towards immunization against COVID-19 and with the lowest level of distrust towards the vaccine were those with sleep disorders. For all other conditions, perceived distrust ranged between 42 and 52%. Fear of adverse events of vaccination or disease reactivation was perceived by 87% of patients with MS/ND and more than 70% of patients with stroke/vascular neurology, neuromuscular disorders, chronic neurological infections, and peripheral neuropathy. Patients with sleep disorders (54%), autonomic disorders (46%), movement disorders (43%), and dementia (43%) were sensed as less fearful of vaccine-related adverse events.

Conclusion

Despite the large body of evidence proving the efficacy and safety of SARS-CoV-2 vaccination, patients with certain neurological disorders still have a surprisingly high percentage of distrust and fear of adverse events. Our observations emphasize the importance of continuous evidence-based information delivery and patient education by treating neurologists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Nervous System DiseasesVaccination HesitancyCOVID-19 VaccinesVaccinationHumansEuropeFemaleMaleMiddle AgedAdultNeurologySurveys and QuestionnairesAgedAdvisory Committees

Stichwörter der Autor:innen

AutoimmuneCOVID-19Disease preventionMultiple sclerosisNeurological diseasePublic healthSARS-CoV-2Vaccination hesitancy

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Graz, Graz, Austria.
  • Division of Neurology, University Medical Centre Maribor, Maribor, Slovenia.
  • Division of Neurology, Grenoble Alpes University, CHU of Grenoble, Grenoble Institute of Neurosciences, INSERM U1216, Grenoble, France.
  • Department of Neurology, Semmelweis University, Budapest, Hungary.
  • Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Zitieren

APA

Hochmeister, S., Rakusa, M., Moro, E., Bereczki, D., Cavallieri, F., Fanciulli, A., Filipović, S. R., Guekht, A., Helbok, R., Boneschi, F. M., Özturk, S., Priori, A., Willekens, B., Ramankulov, D., & Sellner, J. (2025). Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease– a survey of the NeuroCOVID-19 task force of the European Academy of Neurology. Neurological Sciences. https://doi.org/10.1007/s10072-025-08017-w

Vancouver

Hochmeister S, Rakusa M, Moro E, Bereczki D, Cavallieri F, Fanciulli A, et al. Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease– a survey of the NeuroCOVID-19 task force of the European Academy of Neurology. Neurological Sciences. 2025. doi:10.1007/s10072-025-08017-w

BibTeX
@article{Hochmeister2025,
  author = {Hochmeister, Sonja and Rakusa, Martin and Moro, Elena and Bereczki, Daniel and Cavallieri, Francesco and Fanciulli, Alessandra and Filipović, Saša R and Guekht, Alla and Helbok, Raimund and Boneschi, Filippo Martinelli and Özturk, Serefnur and Priori, Alberto and Willekens, Barbara and Ramankulov, Dauren and Sellner, Johann},
  title = {Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease– a survey of the NeuroCOVID-19 task force of the European Academy of Neurology},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-025-08017-w}
}
Kostenlos starten →